In the last 12 months, insiders at Savara Inc ($SVRA) filed 127 transactions with the SEC: 21 open-market purchases totaling $11,215,469 and 7 sales totaling $1,297,218. Net insider sentiment: net buying.
Savara Inc operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Pauls Matthew (CHIEF EXECUTIVE OFFICER) — 12 transactions totaling $2,716,307
- Lowrance David L (Chief Financial Officer) — 25 transactions totaling $1,774,049
- Makhzoumi Mohamad (TenPercentOwner) — 1 transaction totaling $999,999
- Florence Anthony A. Jr. (TenPercentOwner) — 1 transaction totaling $999,999
- Behbahani Ali (TenPercentOwner) — 1 transaction totaling $999,999
View all SEC Filings for Savara Inc (SVRA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | Lowrance David L | Chief Financial Officer | F | Common Stock | 11037 | $5.04 | 527,700.0000 | 216,462,161 | 2.05% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Common Stock | 24850 | $3.35 | 552,550.0000 | 216,462,161 | 4.71% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | F | Common Stock | 16518 | $5.04 | 536,032.0000 | 216,462,161 | 2.99% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Stock Option (Right to Buy) | 80684 | $0.00 | 0.0000 | 216,462,161 | 100.00% | 0.04% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 216,462,161 | 50.00% | 0.03% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Stock Option (Right to Buy) | 130650 | $0.00 | 129,350.0000 | 216,462,161 | 50.25% | 0.06% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Stock Option (Right to Buy) | 43063 | $0.00 | 56,937.0000 | 216,462,161 | 43.06% | 0.02% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 27,500.0000 | 216,462,161 | 31.25% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Stock Option (Right to Buy) | 24850 | $0.00 | 275,150.0000 | 216,462,161 | 8.28% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Common Stock | 80684 | $1.51 | 366,729.0000 | 216,462,161 | 28.21% | 0.04% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | F | Common Stock | 24174 | $5.04 | 342,555.0000 | 216,462,161 | 6.59% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Common Stock | 75000 | $1.59 | 417,555.0000 | 216,462,161 | 21.89% | 0.03% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | F | Common Stock | 23661 | $5.04 | 393,894.0000 | 216,462,161 | 5.67% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Common Stock | 130650 | $1.23 | 524,544.0000 | 216,462,161 | 33.17% | 0.06% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | F | Common Stock | 31885 | $5.04 | 492,659.0000 | 216,462,161 | 6.08% | 0.01% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Common Stock | 43063 | $1.11 | 535,722.0000 | 216,462,161 | 8.74% | 0.02% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | F | Common Stock | 9485 | $5.04 | 526,237.0000 | 216,462,161 | 1.77% | 0.00% |
| March 18, 2026 | Lowrance David L | Chief Financial Officer | M | Common Stock | 12500 | $4.45 | 538,737.0000 | 216,462,161 | 2.38% | 0.01% |
| Feb. 16, 2026 | McCracken Joseph S | Not found | M | Stock Option (right to buy) | 1807 | $0.00 | 0.0000 | 216,462,161 | 100.00% | 0.00% |
| Feb. 16, 2026 | McCracken Joseph S | Not found | M | Common Stock | 1807 | $1.76 | 302,644.0000 | 216,462,161 | 0.60% | 0.00% |
| Dec. 19, 2025 | RAMSAY DAVID A | Not found | S | Common Stock | 20000 | $6.06 | 2,533,642.0000 | 216,462,161 | 0.78% | 0.01% |
| Dec. 16, 2025 | Lowrance David L | Chief Financial Officer | G | Common Stock | 32000 | $0.00 | 286,045.0000 | 216,462,161 | 10.06% | 0.01% |
| Dec. 14, 2025 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | F | Common Stock | 195705 | $6.92 | 1,317,045.0000 | 216,462,161 | 12.94% | 0.09% |
| Dec. 16, 2025 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | G | Common Stock | 128995 | $0.00 | 1,188,050.0000 | 216,462,161 | 9.79% | 0.06% |
| Dec. 14, 2025 | Lutz Robert Matthew | Chief Operating Officer | F | Common Stock | 67760 | $6.92 | 293,977.0000 | 216,462,161 | 18.73% | 0.03% |
| Dec. 14, 2025 | McCabe Kathleen R. | Chief Legal Officer | F | Common Stock | 39350 | $6.92 | 519,232.0000 | 216,462,161 | 7.04% | 0.02% |
| Dec. 14, 2025 | Erickson Anne | Chief Business Officer | F | Common Stock | 62960 | $6.92 | 371,712.0000 | 216,462,161 | 14.48% | 0.03% |
| Dec. 14, 2025 | Lowrance David L | Chief Financial Officer | F | Common Stock | 62960 | $6.92 | 318,045.0000 | 216,462,161 | 16.52% | 0.03% |
| Dec. 9, 2025 | Elam Nevan C | Not found | A | Common Stock | 40000 | $0.00 | 106,887.0000 | 216,462,161 | 59.80% | 0.02% |
| Dec. 9, 2025 | Hawkins Richard J | Not found | A | Common Stock | 40000 | $0.00 | 161,326.0000 | 216,462,161 | 32.97% | 0.02% |
| Dec. 10, 2025 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | G | Common Stock | 23629 | $0.00 | 1,512,750.0000 | 216,462,161 | 1.54% | 0.01% |
| Dec. 9, 2025 | McCracken Joseph S | Not found | A | Common Stock | 40000 | $0.00 | 300,837.0000 | 216,462,161 | 15.34% | 0.02% |
| Dec. 9, 2025 | RAMSAY DAVID A | Not found | A | Common Stock | 40000 | $0.00 | 2,553,642.0000 | 216,462,161 | 1.59% | 0.02% |
| Dec. 9, 2025 | van Es-Johansson An | Not found | A | Common Stock | 40000 | $0.00 | 102,500.0000 | 216,462,161 | 64.00% | 0.02% |
| Dec. 4, 2025 | Wasfi Yasmine | Chief Medical Officer | F | Common Stock | 21992 | $6.37 | 168,008.0000 | 216,462,161 | 11.57% | 0.01% |
| Dec. 2, 2025 | Elam Nevan C | Not found | M | Common Stock | 5860 | $1.46 | 68,360.0000 | 216,462,161 | 9.38% | 0.00% |
| Dec. 2, 2025 | Elam Nevan C | Not found | F | Common Stock | 1473 | $5.81 | 66,887.0000 | 216,462,161 | 2.15% | 0.00% |
| Dec. 2, 2025 | Elam Nevan C | Not found | M | Stock Option (Right to Buy) | 5860 | $0.00 | 0.0000 | 216,462,161 | 100.00% | 0.00% |
| Nov. 14, 2025 | Hawkins Richard J | Not found | M | Stock Option (Right to Buy) | 5860 | $0.00 | 0.0000 | 216,462,161 | 100.00% | 0.00% |
| Nov. 14, 2025 | Hawkins Richard J | Not found | M | Common Stock | 5860 | $1.46 | 121,326.0000 | 216,462,161 | 5.08% | 0.00% |
| Oct. 20, 2025 | Wasfi Yasmine | Chief Medical Officer | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 216,462,161 | 9999.99% | 0.03% |
| Oct. 20, 2025 | Wasfi Yasmine | Chief Medical Officer | A | Common Stock | 35000 | $0.00 | 190,000.0000 | 216,462,161 | 22.58% | 0.02% |
| June 20, 2025 | Hawkins Richard J | Not found | P | Common Stock | 48225 | $2.04 | 115,466.0000 | 198,191,936 | 71.72% | 0.02% |
| May 29, 2025 | McCracken Joseph S | Not found | P | Common Stock | 10000 | $2.08 | 260,837.0000 | 198,191,936 | 3.99% | 0.01% |
| March 31, 2025 | RAMSAY DAVID A | Not found | P | Common Stock | 150000 | $2.78 | 2,513,642.0000 | 198,191,936 | 6.35% | 0.08% |
| Feb. 13, 2025 | Lutz Robert Matthew | Chief Operating Officer | F | Common Stock | 38263 | $2.83 | 361,737.0000 | 198,191,936 | 9.57% | 0.02% |
| Dec. 12, 2024 | Lowrance David L | Chief Financial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 211,847,651 | 9999.99% | 0.14% |
| Dec. 12, 2024 | Erickson Anne | Chief Business Officer | A | Common Stock | 100000 | $0.00 | 452,935.0000 | 211,847,651 | 28.33% | 0.05% |
| Dec. 13, 2024 | Erickson Anne | Chief Business Officer | F | Common Stock | 18263 | $3.21 | 434,672.0000 | 211,847,651 | 4.03% | 0.01% |
| Dec. 12, 2024 | Erickson Anne | Chief Business Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 211,847,651 | 9999.99% | 0.14% |
| Dec. 12, 2024 | Parker Braden C. | Chief Commercial Officer | A | Common Stock | 20000 | $0.00 | 105,000.0000 | 211,847,651 | 23.53% | 0.01% |
| Dec. 12, 2024 | Parker Braden C. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 211,847,651 | 9999.99% | 0.02% |
| Dec. 12, 2024 | Lutz Robert Matthew | Chief Operating Officer | A | Common Stock | 100000 | $0.00 | 400,000.0000 | 211,847,651 | 33.33% | 0.05% |
| Dec. 12, 2024 | Lutz Robert Matthew | Chief Operating Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 211,847,651 | 9999.99% | 0.14% |
| Dec. 12, 2024 | Lowrance David L | Chief Financial Officer | A | Common Stock | 100000 | $0.00 | 442,355.0000 | 211,847,651 | 29.21% | 0.05% |
| Dec. 13, 2024 | Lowrance David L | Chief Financial Officer | G | Common Stock | 12000 | $0.00 | 430,355.0000 | 211,847,651 | 2.71% | 0.01% |
| Dec. 13, 2024 | Lowrance David L | Chief Financial Officer | F | Common Stock | 24350 | $3.21 | 406,005.0000 | 211,847,651 | 5.66% | 0.01% |
| Dec. 16, 2024 | Lowrance David L | Chief Financial Officer | S | Common Stock | 25000 | $3.33 | 381,005.0000 | 211,847,651 | 6.16% | 0.01% |
| Dec. 12, 2024 | Pratt Raymond Dennis | Chief Medical Officer | A | Common Stock | 80000 | $0.00 | 340,050.0000 | 211,847,651 | 30.76% | 0.04% |
| Dec. 12, 2024 | Pratt Raymond Dennis | Chief Medical Officer | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 211,847,651 | 9999.99% | 0.13% |
| Dec. 12, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Common Stock | 400000 | $0.00 | 1,683,674.0000 | 211,847,651 | 31.16% | 0.19% |
| Dec. 13, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | F | Common Stock | 92593 | $3.21 | 1,591,081.0000 | 211,847,651 | 5.50% | 0.04% |
| Dec. 16, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | S | Common Stock | 54702 | $3.31 | 1,536,379.0000 | 211,847,651 | 3.44% | 0.03% |
| Dec. 12, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 900000 | $0.00 | 900,000.0000 | 211,847,651 | 9999.99% | 0.42% |
| Dec. 12, 2024 | Hawkins Richard J | Not found | A | Common Stock | 40000 | $0.00 | 75,241.0000 | 211,847,651 | 113.50% | 0.02% |
| Dec. 16, 2024 | Hawkins Richard J | Not found | S | Common Stock | 8000 | $3.32 | 67,241.0000 | 211,847,651 | 10.63% | 0.00% |
| Dec. 12, 2024 | Elam Nevan C | Not found | A | Common Stock | 40000 | $0.00 | 62,500.0000 | 211,847,651 | 177.78% | 0.02% |
| Dec. 12, 2024 | van Es-Johansson An | Not found | A | Common Stock | 40000 | $0.00 | 62,500.0000 | 211,847,651 | 177.78% | 0.02% |
| Dec. 12, 2024 | McCracken Joseph S | Not found | A | Common Stock | 40000 | $0.00 | 250,837.0000 | 211,847,651 | 18.97% | 0.02% |
| Dec. 12, 2024 | RAMSAY DAVID A | Not found | A | Common Stock | 40000 | $0.00 | 2,363,642.0000 | 211,847,651 | 1.72% | 0.02% |
| Nov. 19, 2024 | McCracken Joseph S | Not found | P | Common Stock | 20000 | $2.95 | 210,837.0000 | 211,847,651 | 10.48% | 0.01% |
| Nov. 18, 2024 | RAMSAY DAVID A | Not found | P | Common Stock | 100000 | $2.88 | 2,323,642.0000 | 211,847,651 | 4.50% | 0.05% |
| Nov. 10, 2024 | Pratt Raymond Dennis | Chief Medical Officer | F | Common Stock | 49950 | $3.97 | 260,050.0000 | 211,847,651 | 16.11% | 0.02% |
| Oct. 21, 2024 | Erickson Anne | Chief Business Officer | F | Common Stock | 381 | $3.57 | 352,935.0000 | 211,847,651 | 0.11% | 0.00% |
| Sept. 25, 2024 | Parker Braden C. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 165,204,652 | 9999.99% | 0.10% |
| Sept. 25, 2024 | Parker Braden C. | Chief Commercial Officer | A | Common Stock | 85000 | $0.00 | 85,000.0000 | 165,204,652 | 9999.99% | 0.05% |
| July 21, 2024 | Erickson Anne | Chief Business Officer | F | Common Stock | 381 | $4.47 | 353,316.0000 | 165,204,652 | 0.11% | 0.00% |
| April 21, 2024 | Erickson Anne | Chief Business Officer | F | Common Stock | 381 | $4.81 | 353,697.0000 | 165,204,652 | 0.11% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | M | Common Stock | 40000 | $1.23 | 116,343.0000 | 0 | 52.40% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | S | Common Stock | 93843 | $4.71 | 22,500.0000 | 0 | 80.66% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | M | Stock Option (Right to Buy) | 1758 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | M | Stock Option (Right to Buy) | 12000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | M | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 28, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | G | Common Stock | 19000 | $0.00 | 1,283,674.0000 | 0 | 1.46% | 0.00% |
| Dec. 28, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | S | Common Stock | 84000 | $4.71 | 1,302,674.0000 | 0 | 6.06% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | M | Common Stock | 1758 | $0.82 | 64,343.0000 | 0 | 2.81% | 0.00% |
| Dec. 28, 2023 | Elam Nevan C | Director | M | Common Stock | 12000 | $1.59 | 76,343.0000 | 0 | 18.65% | 0.00% |
| Dec. 28, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | S | Common Stock | 10000 | $4.71 | 342,355.0000 | 0 | 2.84% | 0.00% |
| Dec. 14, 2023 | Pratt Raymond Dennis | Chief Medical Officer | A | Common Stock | 150000 | $0.00 | 310,000.0000 | 0 | 93.75% | 0.00% |
| Dec. 14, 2023 | Pratt Raymond Dennis | Chief Medical Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 14, 2023 | McCracken Joseph S | Director | A | Common Stock | 22500 | $0.00 | 190,837.0000 | 0 | 13.37% | 0.00% |
| Dec. 14, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | F | Common Stock | 30438 | $4.45 | 212,355.0000 | 0 | 12.54% | 0.00% |
| Dec. 14, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | A | Common Stock | 160000 | $0.00 | 372,355.0000 | 0 | 75.35% | 0.00% |
| Dec. 15, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | G | Common Stock | 20000 | $0.00 | 352,355.0000 | 0 | 5.37% | 0.00% |
| Dec. 14, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 14, 2023 | Lutz Robert Matthew | Chief Operating Officer | A | Common Stock | 160000 | $0.00 | 300,000.0000 | 0 | 114.29% | 0.00% |
| Dec. 14, 2023 | Lutz Robert Matthew | Chief Operating Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 14, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | F | Common Stock | 109680 | $4.45 | 936,674.0000 | 0 | 10.48% | 0.00% |
| Dec. 14, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Common Stock | 450000 | $0.00 | 1,386,674.0000 | 0 | 48.04% | 0.00% |
| Dec. 14, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 14, 2023 | RAMSAY DAVID A | Director | A | Common Stock | 22500 | $0.00 | 2,223,642.0000 | 0 | 1.02% | 0.00% |
| Dec. 14, 2023 | van Es-Johansson An | Director | A | Common Stock | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 14, 2023 | Hawkins Richard J | Director | A | Common Stock | 22500 | $0.00 | 35,241.0000 | 0 | 176.60% | 0.00% |
| Dec. 14, 2023 | Elam Nevan C | Director | A | Common Stock | 22500 | $0.00 | 62,585.0000 | 0 | 56.13% | 0.00% |
| Dec. 14, 2023 | Sun Ricky | Not found | A | Common Stock | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 11, 2023 | Elam Nevan C | Director | M | Stock Option (Right to Buy) | 10841 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2023 | Hawkins Richard J | Director | M | Common Stock | 10841 | $0.82 | 12,741.0000 | 0 | 570.58% | 0.00% |
| Dec. 11, 2023 | Hawkins Richard J | Director | M | Stock Option (Right to Buy) | 10841 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2023 | Elam Nevan C | Director | M | Common Stock | 10841 | $0.82 | 40,085.0000 | 0 | 37.07% | 0.00% |
| July 17, 2023 | Chang Carmen | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | BASKETT FOREST | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Behbahani Ali | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Florence Anthony A. Jr. | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Makhzoumi Mohamad | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Mathers Edward T | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | SANDELL SCOTT D | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Walker Paul Edward | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Yang Rick | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| July 17, 2023 | Growth Equity Opportunities 17, LLC | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| June 26, 2023 | Pratt Raymond Dennis | Chief Medical Officer | P | Common Stock | 6500 | $2.93 | 160,000.0000 | 0 | 4.23% | 0.00% |
| May 24, 2023 | RAMSAY DAVID A | Director | P | Common Stock | 50000 | $2.56 | 2,151,142.0000 | 0 | 2.38% | 0.00% |
| May 25, 2023 | RAMSAY DAVID A | Director | P | Common Stock | 12876 | $2.57 | 2,164,018.0000 | 0 | 0.60% | 0.00% |
| May 26, 2023 | RAMSAY DAVID A | Director | P | Common Stock | 37124 | $2.63 | 2,201,142.0000 | 0 | 1.72% | 0.00% |
| Feb. 24, 2023 | Lutz Robert Matthew | Chief Operating Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Lutz Robert Matthew | Chief Operating Officer | A | Common Stock | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2022 | RAMSAY DAVID A | Director | P | Common Stock | 7000 | $1.54 | 2,072,142.0000 | 0 | 0.34% | 0.00% |
| Dec. 30, 2022 | RAMSAY DAVID A | Director | P | Common Stock | 29000 | $1.55 | 2,101,142.0000 | 0 | 1.40% | 0.00% |